echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Daiichi Sankyo dismantles nearly 4.7 billion yen of mature drugs, accelerating the transformation into the field of oncology

    Daiichi Sankyo dismantles nearly 4.7 billion yen of mature drugs, accelerating the transformation into the field of oncology

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to Nihon Keizai Shimbun, on the 26th local time, Daiichi Sankyo announced at the board meeting that it had passed a resolution to release 11 mature drugs including the antihypertensive drug "Acecol" and the antibacterial drug "Banan" in Japan.


    As of March 31, 2020, the sales price of these 11 drugs was 4.


    In fact, as early as July 2018, Daiichi Sankyo had sold the manufacturing and marketing rights of 41 mature drugs in Japan to Alfresa Pharmaceuticals.


    In this regard, Daiichi Sankyo said that due to the emergence of generic drugs, the profitability of generic drugs has been lower than that of new drugs.


    management

    The company plans to develop 7 new molecular entities from 2018 to 2025.


    FDAStomach cancer

    In addition, at almost the same time, Daiichi Sankyo also recruited Ken Takeshita from Gilead’s cell therapy business unit and appointed him as the head of Daiichi Sankyo’s global R&D department and the interim head of clinical research.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.